CME Group (CME) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
Annual Meeting of Shareholders scheduled for May 14, 2026, with proxy materials filed and available for review.
Shareholders are encouraged to read all proxy materials before voting, as they contain important information about the meeting and company matters.
Several candidates for Board of Directors positions present their qualifications, experience, and vision for the company’s future.
Voting matters and shareholder proposals
Shareholders are urged to vote using their unique 16-digit control numbers, with instructions provided for obtaining these if lost.
Voting can be conducted online or by phone, with Broadridge serving as Inspector of Election.
Board of directors and corporate governance
Multiple candidates seek re-election or election to the Board, emphasizing diverse trading backgrounds and decades of industry experience.
Candidates highlight committee roles, including risk, finance, audit, and compensation, and stress advocacy for market participants.
Board members stress the importance of adapting to technological change and maintaining strong governance.
Candidates note their participation in various CME Group and industry committees, reflecting broad governance involvement.
Latest events from CME Group
- Q2 2026 saw record revenue, strong market data growth, and robust shareholder returns.CME
Q2 202624 Jul 2026 - Record revenue, earnings, and trading volumes, with strong innovation and capital returns.CME
Q4 202522 Jul 2026 - Record Q1 2026 revenue and net income driven by surging global trading volumes and innovation.CME
Q1 202622 Jul 2026 - S&P 500 ESG Index rebranded as Scores and Screens, fueling growth in liquid ESG investment products.CME
Beyond ESG with Understanding the S&P 500 ESG Index Ecosystem Conference9 Jul 2026 - Strong volumes, new product launches, and tech-driven change shape a dynamic market outlook.CME
Piper Sandler Global Exchange and Trading Conference 20249 Jul 2026 - Record Q2 revenue, net income, and trading volumes with broad-based growth and innovation.CME
Q2 20248 Jul 2026 - Director election amendments failed; all nominated directors reelected; no shareholder questions.CME
AGM 20269 Jun 2026 - CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.CME
Piper Sandler Global Exchange and Fintech Conference4 Jun 2026 - Class B Proposals seek to modernize board structure and offer payments to shareholders if approved.CME
Proxy filing19 May 2026